TFS HealthScience is a global Contract Research Organization (CRO) that supports biotechnology and pharmaceutical companies throughout their entire clinical development journey. In partnership with customers, we build solution-driven teams working for a healthier future. Bringing together nearly 700 professionals, TFS delivers tailored clinical research services in more than 40 countries and supports customers with comprehensive solutions through three strong business models: Clinical Development Services (CDS), which provides full-service support at all stages of the clinical development process, Strategic Resourcing Solutions (SRS), which offers expert insourcing and targeted recruitment services, and Functional Services (FSP), to provide customers with strategic workforce management solutions. TFS performs full service or individual functional services, supporting specific components of the clinical trial, in all the countries where they operate. The company has significant experience across all phases of clinical drug development with particular strengths in Phase I/II and Late Phase RWE trials. A significant proportion of TFS’s business comes from biotechnology and small to mid-size pharmaceutical companies and, their therapeutic experience reflects their broad range of target indications. TFS demonstrates scientific and medical competence across populations and therapeutics, with industry-leading capabilities in:

• Dermatology, Immunology and Inflammatory Diseases
• Hemato-Oncology
• Ophthalmology
• Internal Medicine including Neurology & Respiratory
• Pediatrics, Rare Diseases and Orphan Drugs
• Real World Evidence